Crohn's disease 1 , 2 and ulcerative colitis, the two main types of chronic inflammatory
bowel disease, are multifactorial conditions of unknown aetiology. A susceptibility locus for …

Colorectal cancer (CRC) is a frequently lethal disease with heterogeneous outcomes and
drug responses. To resolve inconsistencies among the reported gene expression–based CRC …

The anti-epidermal growth factor receptor (anti-EGFR) cetuximab has been proven to be
efficient in metastatic colorectal cancer. The molecular mechanisms underlying the clinical …

Background Colon cancers with high-frequency microsatellite instability have clinical and
pathological features that distinguish them from microsatellite-stable tumors. We investigated …

Background Following the discovery that mutant KRAS is associated with resistance to anti-epidermal
growth factor receptor (EGFR) antibodies, the tumours of patients with metastatic …

We introduce the Microenvironment Cell Populations-counter (MCP-counter) method, which
allows the robust quantification of the absolute abundance of eight immune and two stromal …

Background Colon cancer (CC) pathological staging fails to accurately predict recurrence,
and to date, no gene expression signature has proven reliable for prognosis stratification in …

CROHN'S disease (CD) and ulcerative colitis are the major forms of chronic inflammatory
bowel diseases in the western world, and occur in young adults with an estimated prevalence …

Breast cancer is the most common cancer among women. Common variants at 27 loci have
been identified as associated with susceptibility to breast cancer, and these account for ∼9…

Hepatocellular carcinomas (HCCs) are a heterogeneous group of tumors that differ in risk
factors and genetic alterations. We further investigated transcriptome‐genotype‐phenotype …